Back

Vascular endothelial growth factor-C and cardiovascular mortality in patients with suspected and a history of coronary artery disease: from the ANOX study

28 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Secondary prevention Secondary Prevention ESC Premium Access ESC Congress 2018

About the speaker

Photo
Mr Kyohma Wada

Kyoto (Japan)

32 More presentations in this session

Presentation thumbnail
Associate Professor M. Proietti (Milan, IT)
Abstract Slides
Presentation thumbnail
Professor G. Giannakoulas (Thessaloniki, GR)
Abstract Slides
Presentation thumbnail
Associate Professor M. Zeitouni (Paris, FR)
Abstract Slides
Presentation thumbnail
Mr O. Mohammad (Ludwigshafen, DE)
Abstract
Presentation thumbnail
Doctor P. Giovanardi (Modena, IT)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 7 - Secondary prevention

The Event

Event poster

ESC Congress 2018

28 August 2018 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Vascular endothelial growth factor c serum level at admission and discharge provides different prognostic values in acute heart failure.
21 May 2023
thumbnail
Webinar
Percutaneous interventions in patients with coronary artery disease and specific clinical conditions - IC Core Curriculum 6
9 November 2022
thumbnail
Congress Presentation
Involvement of growth differentiation factor 15 in paradoxical relationship between body mass index and mortality in patients with suspected or known coronary artery disease; The ANOX Study
29 August 2022
thumbnail
Congress Presentation
Prognostic value of vascular inflammation biomarkers over clinical risk factors for cardiovascular risk : a meta-analysis
17 April 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources